EU regulators see info from rivals, customers in Catalent sale to Novo Holdings - Reuters
European Union seeks input from rival pharmaceutical firms on Novo Holdings' $16.5 billion acquisition of Catalent.
Hosted on MSN11mon
Novo Holding-backed Danish startup raises €23m in Series A
The Novo Holdings-founded Danish startup Hoba Therapeutics has raised €23m ($24.7m) in a Series A financing round to develop its lead candidate HB-086. The principal investors include Indaco ...
Yahoo Finance28d
Consumer groups ask FTC to block Novo Holdings-Catalent deal
NEW YORK (Reuters) -U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk ...
Reuters11d
EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6
EU antitrust regulators to decide on Novo Holdings' Catalent buy by Dec. 6 Novo announced $16.5 billion acquisition in February Novo Nordisk seeking to boost output of Wegovy weight-loss drug ...
EU regulators see info from rivals, customers in Catalent's sale to Novo Holdings
European Union antitrust officials are asking rival pharmaceuticals firms for their input on Novo Holdings planned $16.5 ...